Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Methods and Findings in Experimental and Clinical Pharmacology|March 9, 2011
[Classification of chronic graft-versus-host disease]T Caballero Velázquez, J A Pérez Simón
British Journal of Cancer|March 9, 2024
Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptionsM Medrano, M Contreras, T Caballero-Velázquez, et al.
Leukemia Research Reports|December 28, 2013
Differential cytogenetic profile in advanced chronic myeloid leukemia with sequential lymphoblastic and myeloblastic blast crisisC Calderón-Cabrera, I Montero, R M Morales, et al.
International Journal of Laboratory Hematology|September 30, 2015
NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expressionS Burillo-Sanz, R M Morales-Camacho, T Caballero-Velázquez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Oral beclomethasone dipropionate for the treatment of gastrointestinal chronic graft-versus-host diseaseFernanda N Villanueva, Jose Antonio Pérez-Simón, Fernando F Silva, et al.
Hematological Oncology|March 8, 2016
RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomesS Burillo-Sanz, M T Vargas, R M Morales-Camacho, et al.
Bone Marrow Transplantation|September 26, 2019
Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantationT Caballero-Velázquez, C Calderón-Cabrera, L López-Corral, et al.
Bone Marrow Transplantation|April 8, 2025
GvHD prophylaxis with tacrolimus, sirolimus, and mycophenolate mofetil after reduced intensity conditioning hematopoietic stem cell allogeneic transplantationL Lopez-Corral, C Blázquez-Goñi, E Pérez-López, et al.
Pageof 1